期刊文献+

Mx3000p^(TM)实时荧光定量PCR仪HBV-DNA检测系统的性能验证 被引量:5

Performance verification of Mx3000p^(TM) real-time fluorescent quantitative PCR HBV-DNA detection system
下载PDF
导出
摘要 目的验证Mx3000p^(TM)实时荧光定量PCR仪HBV-DNA检测系统的性能,确定该系统是否稳定可靠,是否满足临床需求。方法参考美国临床实验室标准化委员会(NCCLS)颁布的EP系列文件及中国合格评定国家认可委员会(CNAS)对实验室检测系统评估的要求,对Mx3000p^(TM)实时荧光定量PCR仪进行性能评价,主要从以下几个方面进行:精密度、正确度、线性、测量和/或可报告范围及抗干扰能力等。结果 Mx3000p^(TM)实时荧光定量PCR仪HBV-DNA检测系统的批内精密度(批内CV)分别为5.21%(低浓度)、3.40%(高浓度);批间精密度(批间CV)为3.45%(中值),1.39%(高值);准确度评估以参加能力验证/室间质评的项目来判断,项目PT成绩为100%,通过;线性回归方程是Y=1.010X+0.004,R^2=0.991线性范围为5.00×10~2~2.84×10~8 U/m L;临床可报告范围为10~3~10~8 U/mL;抗干扰能力评估:检测5个样品中至少个样品测量结果与分析物预期浓度偏倚<±7.5%。结论 Mx3000p^(TM)实时荧光定量PCR仪HBV-DNA检测系统具有良好的精密度、准确度、线性范围、临床可报告范围、抗干扰能力,可用于临床标本检测。 Objective To verify the performance of Mx3000p^TM real-time fluorescent quantitative PCR HBV-DNA detection system, in order to confirm its stability, accuracy and reliability. Methods According to the EP series of document issued by the National Committee for Clinical Laboratory Standards(NCCLS) and requirements for the assessment of laboratory testing systems issued by China National Accreditation Service for Conformity Assessment(CNAS), the precision, accuracy, linear, measurement and/or reportable range and anti-interference ability of Mx3000p^TM real-time fluorescent quantitative PCR were performed and evaluated. Results The within-batch precision CV of low value and high value of Mx3000p^TM real-time fluorescent quantitative PCR HBV-DNA testing system was 5.21% and 3.40%,respectively, and the between-batch precision CV of middle value and high value was 3.45% and 1.39% respectively.The correctness was valuated by participating in verification of room to judge the qualitative evaluation of the project and PT result was 100%. The linear regression equation was Y = 1.010 X +0.004, R^2= 0.991. The linearity range was 5.00×10^2-2.84×10^8 U/m L, the clinical reportable range was 10^3-10^8 U/m L; five samples was tested to assess the anti-interference capability, four sample measurement results according to the concentration of expected bias was 〈±7.5%. Conclusion The performance of Mx3000p^TM real-time fluorescent quantitative PCR HBV-DNA testing system conforms to the requirements in precision, accuracy, linear range, clinical reportable range, anti-interference ability and can be applied to the clinical detection.
作者 王娇 钱军 石英 蔡旺喜 刘光忠 WANG Jiao1,2, QIAN Jun1,2, SHI Ying1,2, CAI Wangxi1,2, LIU Guangzhong1,2(1.Department of Clinical Laboratory, Hubei Provincial Hospital of Traditional Chinese Medicine, Hubei Province, Wuhan 430074, China; 2.Hubei Province Academy of Traditional Chinese Medicine, Hubei Province, Wuhan 430074, Chin)
出处 《中国医药导报》 CAS 2018年第15期65-68,共4页 China Medical Herald
关键词 HBV-DNA 检测系统 性能验证 HBV-DNA Detection system Performance verification
  • 相关文献

参考文献6

二级参考文献45

  • 1段学光,丁程伟,吴连辉,杨明明.UF-1000i尿液有形成分分析仪性能评价及应用[J].医学信息(医学与计算机应用),2014(18):205-206. 被引量:3
  • 2李晓斐,张萍,刘庆丽.临床基因扩增检验实验室的质量保证[J].职业与健康,2006,22(3):174-176. 被引量:4
  • 3毕波,吕元.定量检测方法学性能验证的系统设计[J].中华检验医学杂志,2007,30(2):143-145. 被引量:153
  • 4余南,甘明,詹希美,陈小坚.乙型肝炎病毒核酸定量检测中不确定度的研究[J].热带医学杂志,2007,7(4):310-314. 被引量:19
  • 5Akyar I. ISO15189 accreditation in clinical microbiology laborato- ry: general concepts and the status in our labarotory[ J]. Mikrobiy- ol Bul,2009,43 (4) : 683 -697.
  • 6中国合格评定国家认可委员会.CNAS-CL41医学实验室质量和能力认可准则在体液学检验领域的应用说明.2012,9.
  • 7CLSI. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline--Third Edition. CLSIDoeument EP28- A3C : Wayne, PA : Clinical and Laboratory Standards Institute, 2010.
  • 8王治国.临床检验质量控制技术.第2版.北京:人民卫生出版社,2010:41-46.
  • 9CNAS-CL02.医学实验室质量和能力认可准则(IS015189)[S].2012.
  • 10CLSI. User verification of performance for precision and trueness., approved guideline-second edition [S]. EP15- A2,2005.

共引文献44

同被引文献44

引证文献5

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部